ROS-mediated SRMS activation confers platinum resistance in ovarian cancerYunhan Jiang(The University of Texas Health Science Center at San Antonio), Lingtao Jin(Emory University)OncogeneApril 5, 202310.1038/s41388-023-02679-6Cited by 14SaveCiteExport RISWatch citationsRelated PapersEx vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine|Lung Cancer|2024|21<em>Ex Vivo</em> Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized Medicine|Preprints.org|2023|0